Linong Ji, Professor
Peking University People's Hospital · People's Hospital of Peking Universty
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Linong Ji, Professor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:55 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05227677 · Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 DiabetesAsahi Kasei Therapeutics Corporation · completed · Type 2 Diabetes Mellitus · principal investigator
- Ph3NCT03608358 · Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinAstraZeneca · terminated · Type 2 Diabetes Mellitus · principal investigator
- Ph3NCT02104804 · Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlAstraZeneca · completed · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.